Lyso-Sulfatide Binds Factor Xa and Inhibits Thrombin Generation by the Prothrombinase Complex

Area of Science:

• Biochemistry
• Hematology
• Lipid research

Background:

• Phospholipids are key regulators of blood coagulation.
• The role of sphingolipids in coagulation remains largely unexplored.
• Lysosulfatide (lyso-SF) is a specific type of sphingolipid.

Purpose of the Study:

• To investigate the anticoagulant activity of lysosulfatide (lyso-SF).
• To elucidate the mechanism by which lyso-SF affects blood coagulation.
• To determine if lyso-SF directly inhibits factor Xa (fXa) enzymatic activity.

Main Methods:

• One-stage plasma clotting assays using purified clotting factors.
• Prothrombin (II) activation assays with fXa/factor Va (fVa) and phospholipids.
• Enzymatic hydrolysis assays with small peptide substrates.
• Surface plasmon resonance (SPR) and fluorescence studies to detect binding.

Main Results:

• Lysosulfatide (lyso-SF) demonstrated significant anticoagulant activity.
• Lyso-SF inhibited prothrombin (II) activation mediated by fXa/fVa/phospholipids.
• Lyso-SF did not inhibit the enzymatic hydrolysis of peptide substrates by fXa.
• SPR and fluorescence studies confirmed direct binding of lyso-SF to factor Xa (fXa).

Conclusions:

• Lysosulfatide (lyso-SF) is an anticoagulant lipid that inhibits factor Xa (fXa) activity.
• Inhibition occurs when fXa is bound to phospholipids or factor Va (fVa).
• Lyso-SF binds to fXa domains distinct from the active site and Gla domain.
• Certain sphingolipids may regulate fXa activity without direct enzymatic inhibition.